The Brilliant Achievement Award was presented to Human Genome Sciences CEO Thomas Watkins at the 16th Annual Chinese Biopharmaceutical Association Conference.
"The CBA Brilliant Achievement Award is given to honor outstanding individuals who have made significant contributions to science, technology, or business development in the bio pharmaceutical fields." said Zhifeng Long, Ph.D. Chair of the Conference Organizing Committee who was also honored and name President of the CBA for 2011 - 2012.
Watkins discussed the journey of Human Genome Sciences from its formation and his place as CEO starting in 2004. The Rockville based company is about to embark on selling its first commercial drug called Benlysta, the first treatment for Lupus in over 56 years. It received approval from the FDA in March.